07.02.2013
- Seven European drugmakers are to pool their research efforts with academic scientists and smaller companies in a new €196 million ($265 million) project designed to find tomorrow's...
06.02.2013
- Hikal, the outsourcing partner for leading global life sciences companies, today announced its financial results for the third quarter ended 31st December, 2012. Financial...
06.02.2013
- GlaxoSmithKline, Britain's biggest drugmaker, renewed its promise to return to growth this year, after failing to deliver a hoped-for sales and margin recovery in 2012. GSK also...
06.02.2013
- Biogen is to take full ownership of blockbuster multiple sclerosis drug Tysabri after agreeing to pay Irish partner Elan $3.25 billion plus future royalties on sales of the drug...
01.02.2013
- Merck & Co's quarterly results beat estimates, but the drugmaker issued a cautious 2013 profit forecast and said it will delay seeking approval for a high-profile osteoporosis drug...
31.01.2013
- EU antitrust regulators stepped up their fight against companies blocking the market entry of cheaper generic medicines, with charges against Johnson & Johnson and Novartis over a...
31.01.2013
- The world's biggest insulin producer Novo Nordisk raised sales and profit forecasts for 2013 on hopes its new Tresiba drug will soon win approval in the United States and add...
31.01.2013
- Spain's Constitutional Court has stopped the Madrid region adding a flat fee on prescription medicines while it discusses the constitutionality of such a charge, which authorities...
